National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Meeting

Published date10 January 2020
Citation85 FR 1320
Record Number2020-00192
SectionNotices
CourtNational Institutes Of Health
Federal Register, Volume 85 Issue 7 (Friday, January 10, 2020)
[Federal Register Volume 85, Number 7 (Friday, January 10, 2020)]
                [Notices]
                [Page 1320]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2020-00192]
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                National Institutes of Health
                National Institute of Arthritis and Musculoskeletal and Skin
                Diseases; Notice of Meeting
                 Pursuant to section 10(d) of the Federal Advisory Committee Act, as
                amended, notice is hereby given of a meeting of the National Arthritis
                and Musculoskeletal and Skin Diseases Advisory Council.
                 The meeting will be open to the public as indicated below, with
                attendance limited to space available. Individuals who plan to attend
                and need special assistance, such as sign language interpretation or
                other reasonable accommodations, should notify the Contact Person
                listed below in advance of the meeting.
                 The meeting will be closed to the public in accordance with the
                provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
                U.S.C., as amended. The grant applications and the discussions could
                disclose confidential trade secrets or commercial property such as
                patentable material, and personal information concerning individuals
                associated with the grant applications, the disclosure of which would
                constitute a clearly unwarranted invasion of personal privacy.
                 Name of Committee: National Institute of Arthritis and
                Musculoskeletal and Skin Diseases Advisory Council.
                 Date: February 4, 2020.
                 Open: 8:30 a.m. to 12:00 p.m.
                 Agenda: To review program documents and policies.
                 Place: Porter Neuroscience Research Center, Building 35A, Room:
                620/630, 35 Convent Drive, Bethesda, MD 20892.
                 Closed: 1:00 p.m. to 5:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: Porter Neuroscience Research Center, Building 35A, Room:
                620/630, 35 Convent Drive, Bethesda, MD 20892.
                 Contact Person: Melinda Nelson, Acting Director, Grants
                Management Branch, National Institute of Arthritis and
                Musculoskeletal and Skin Diseases, 45 Center Drive, Natcher
                Building, Room 5A49, Bethesda, MD 20892, (301) 594-3535,
                [email protected].
                 Any interested person may file written comments with the
                committee by forwarding the statement to the Contact Person listed
                on this notice. The statement should include the name, address,
                telephone number and when applicable, the business or professional
                affiliation of the interested person.
                 In the interest of security, NIH has instituted stringent
                procedures for entrance onto the NIH campus. All visitor vehicles,
                including taxicabs, hotel, and airport shuttles will be inspected
                before being allowed on campus. Visitors will be asked to show one
                form of identification (for example, a government-issued photo ID,
                driver's license, or passport) and to state the purpose of their
                visit.
                (Catalogue of Federal Domestic Assistance Program Nos. 93.846,
                Arthritis, Musculoskeletal and Skin Diseases Research, National
                Institutes of Health, HHS)
                 Dated: January 6, 2020.
                Miguelina Perez,
                Program Analyst, Office of Federal Advisory Committee Policy.
                [FR Doc. 2020-00192 Filed 1-9-20; 8:45 am]
                BILLING CODE 4140-01-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT